Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer. Kelley RK. N Engl J Med 2020;382:1953-1955.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelley RK. Atezolizumab plus Bevacizumab - A Landmark in Liver Cancer. N Engl J Med 2020;382:1953-1955.
PMID: 32402168